Navigation Links
Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000
Date:8/22/2008

Company's core therapeutic areas in addition to several partnered or partnerable programs. The most advanced compounds in development include, VALSTAR(TM) for bladder cancer, NEBIDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and the octreotide implant for acromegaly.

About MDP

The Microbicides Development Programme (MDP) is an Afro-European partnership to develop vaginal microbicides for the prevention of HIV transmission. MDP is coordinated jointly by Imperial College, London, and the Clinical Trials Unit of the UK Medical Research Council. Partner institutions in Africa are University Teaching Hospital, Lusaka, Zambia; Medical Research Council Uganda Virus Research Institute, Entebbe; African Medical and Research Foundation and National Institute for Medical Research, Mwanza, Tanzania; the Africa Centre for Health and Population Studies, KwaZulu Natal, South Africa; South African Medical Research Council, Durban; and the Reproductive Health and HIV Research Unit, Department of Obstetrics and Gynaecology, University of Witwatersrand, Johannesburg, South Africa. In Mozambique, there are two new MDP sites at the rural Manhica Health Research Centre and at Mavalane Hospital in the urban capital of Maputo. European partners include the London School of Hygiene and Tropical Medicine, St. George's Hospital, London, and the Universities of York, Southampton and Barcelona. Clinical sites are located in South Africa, Tanzania, Uganda, Zambia and Mozambique.

MDP has built a vigorous multicultural and multidisciplinary research network ready to undertake future work of comparable importance and complexity. Years of working collegially have built cohesiveness, efficiency and mutual trust among the scientists, clinical staff, data managers, and other professionals and support staff comprising this Afro-European and pan-African clinical trial network, as well as sound relationships wit
'/>"/>

SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
2. Indevus Announces Submission of New Drug Application
3. Indevus Pharmaceuticals Reports Positive Results of Phase II Octreotide Implant Trial
4. Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
5. Indevus Pharmaceuticals Provides Update on PRO 2000 Program
6. Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
7. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
8. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
9. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... WHITEHOUSE STATION, N.J. , Sept. 19, 2014 Merck ... the United States and Canada , ... on Desafiando La Diabetes: Logra Tus Metas , an educational ... of their blood sugar -- a key treatment goal to help ... the United States are at a higher risk for ...
(Date:9/19/2014)... 19, 2014 UBM Medica US announces that  ... community to help oncologists and other clinicians gain a ... use of targeted therapies and immunotherapies, discusses some of ... Every September, Blood Cancer Awareness ... awareness about blood cancers—helping to increase survival rates and ...
(Date:9/19/2014)... 2014 According to market ... Mobile, Industrial, & Laboratory), Industry (Food, Pharmaceutical, Biotechnology, ... Rotary) & Geography - Global Trends & Forecast ... the lyophilization market on the basis of various ... of the market size of each of these ...
Breaking Medicine Technology:Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Lyophilization Market Worth $5,121.5 Million by 2019 2Lyophilization Market Worth $5,121.5 Million by 2019 3
(Date:9/19/2014)... September 19, 2014 Unbound , an ... families in regions of the Philippines being affected by both ... than 1,060 families evacuated to the nearest public schools while ... heavy rain and gusty winds to portions of the northern ... flooding. Some homes filled with more than 10 feet of ...
(Date:9/19/2014)... cancers have abnormally upregulated chemical signals related to ... during tumor formation is not fully understood. , ... both researchers in the department of Pathology and ... University of Pennsylvania, and colleagues report that TIPE3, ... targeting these pathways. , Lipid second messengers play ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 According to ... of the embattled blood-thinner Xarelto, named as defendants in ... Common Pleas, have moved the court to dismiss those ... not have sufficient connection with Philadelphia.* The cases include, ... al. (No. 140304328; Pa. Comm. Pls., Philadelphia Cty.), which ...
(Date:9/19/2014)... Sept. 19, 2014 (HealthDay News) -- Pregnant women who live ... or low birth weight babies, a new study suggests. ... Canada, and found that expectant mothers who lived in a ... a 20 percent lower risk of very preterm birth (before ... preterm birth (30 to 36 weeks). Babies born to ...
(Date:9/19/2014)... 19, 2014 The Alliance for ... with the National Fire Protection Association (NFPA), a ... formalized today in a Memorandum of Understanding signed ... workers and other stakeholders with information, guidance and ... the health and safety of workers in ready-made ...
Breaking Medicine News(10 mins):Health News:Double Threat in Philippines Displaces Thousands of Unbound Families 2Health News:New cancer drug target involving lipid chemical messengers 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 2Health News:Xarelto Makers Seek Dismissal of Cases Brought in Philadelphia, Notes Rottenstein Law Group LLP 3Health News:Do Greener Neighborhoods Produce Healthier Babies? 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 2Health News:Alliance for Bangladesh Worker Safety and NFPA Sign Memorandum of Understanding to Strengthen Safety in Bangladesh Garment Factories 3
... , FRIDAY, Aug. 12 (HealthDay News) -- Religious ... facing hardship or conflict, a new study indicates. ... such link. Not only are fewer people religious ... in regions where there,s hardship and strife, regardless of ...
... HealthDay Reporter , THURSDAY, Aug. 11 (HealthDay News) -- Depressed ... suggests. "We know that stroke can increase risk of ... said study author An Pan, a research scientist at the ... associated with hormonal changes in the body and affects chemicals ...
... (HealthDay News) -- Obstructive sleep apnea (OSA) and sleepiness rapidly ... machines, a new study finds. CPAP is a common ... during sleep due to the repeated blockage of the upper ... stream of air through a mask or nose piece the ...
... of continuous positive airway pressure machines (CPAP) for patients ... the therapy is withdrawn, according to Swiss research. ... the American Thoracic Society,s American Journal of Respiratory ... obstructive sleep apnea who are established on CPAP treatment, ...
... in illness and recovery is a primary influence upon ... a first-of-its-kind study has discovered. Outreach and education efforts ... concerns and improve health care quality in this rapidly ... fasting occurring this month is but one of many ...
... Researchers from the Indiana University have identified common ... in Intensive Care Units (ICUs). The study, published ... and Hospital Epidemiology , the journal of the ... lessons learned from six ICUs as they implemented ...
Cached Medicine News:Health News:Religion Might Boost Happiness in Times of Stress 2Health News:Depressed Women Could Face Raised Risk of Stroke 2Health News:Depressed Women Could Face Raised Risk of Stroke 3Health News:Withdrawal of CPAP therapy results in rapid recurrence of OSA 2Health News:Religious beliefs shape health care attitudes among US Muslims 2Health News:Religious beliefs shape health care attitudes among US Muslims 3Health News:Common themes emerge in hospitals' anti-MRSA efforts: Study 2
... is a mechanical catheter intended to percutaneously ... access grafts. The disposable catheter requires no ... spiral shaft which extends beyond the 6F ... tip. In use, the tip spins to ...
... HYDROLYSER Percutaneous Thrombectomy Catheter is ... for rapid, effective and easy removal ... shunts. The HYDROLYSER catheter provides an ... thrombolytic therapy. ,Compatible with ...
Introduced more than 30 years ago by Dr. Thomas J. Fogarty, these embolectomy catheters are indicated for the removal of fresh, soft emboli and thrombi from vessels in the arterial system....
... The AVX catheter is designed to ... 12mm. High-pressure saline jets travel backwards ... to create a low pressure zone ... drawn into the catheter where it ...
Medicine Products: